Form 8-K - Current report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________________________

Form 8-K

_____________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 4, 2023

ADVANSIX INC.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction

of incorporation)

1-37774

(Commission File Number)

81-2525089

(I.R.S. Employer

Identification No.)

300 Kimball Drive, Suite 101

Parsippany, New Jersey 07054

(Address of principal executive offices)

Registrant’s telephone number, including area code: (973) 526-1800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	ASIX	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 2.02 Results of Operations and Financial Condition.

On August 4, 2023, AdvanSix Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2023. A copy of the press release is furnished herewith as Exhibit 99.1.

ITEM 8.01 Other Events.

Dividend

On August 4, 2023, the Company announced that its Board of Directors declared a cash dividend of $0.16 per share on the Company's common stock. The dividend will be paid on August 29, 2023 to stockholders of record as of the close of business on August 15, 2023.

The Company's announcement of the dividend is included in the press release furnished herewith as Exhibit 99.1.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits


Exhibit Number						Description

99.1						Press Release dated August 4, 2023

104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 4, 2023


			AdvanSix Inc.

			By:			/s/ Achilles B. Kintiroglou
			Name:			Achilles B. Kintiroglou
			Title:			Senior Vice President, General Counsel and Corporate Secretary

Exhibit 99.1

News Release

ADVANSIX ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS

Sales of $428 million, down 27% versus prior year

Earnings Per Share of $1.16; Adjusted Earnings Per Share of $1.25

Returned $19 million of cash to shareholders through repurchases and dividends in 2Q23

Announced 10% increase in quarterly dividend to $0.16 per share

Parsippany, N.J., August 4, 2023 - AdvanSix (NYSE: ASIX) today announced its financial results for the second quarter ending June 30, 2023. Overall, the Company delivered solid earnings and cash flow results amid a continued dynamic macro environment.

Second Quarter 2023 Summary

•Sales down approximately 27% versus prior year driven by 19% unfavorable impact of market-based pricing, 6% lower raw material pass-through pricing, and 2% lower volume

•Net Income of $32.7 million, a decrease of $32.4 million versus the prior year

•Adjusted EBITDA of $65.8 million, a decrease of $39.6 million versus the prior year

•Cash Flow from Operations of $35.0 million, a decrease of $60.9 million versus the prior year

•Capital Expenditures of $19.3 million, an increase of $1.5 million versus the prior year

•Free Cash Flow of $15.7 million, a decrease of $62.4 million versus the prior year

•Repurchased 410,862 shares for approximately $14.9 million in 2Q23

“AdvanSix successfully delivered solid earnings and cash flow results in the second quarter against a record prior year,” said Erin Kane, president and CEO of AdvanSix. “The AdvanSix team executed well within a mixed set of dynamics across the portfolio. We captured strong in-season demand for plant nutrients in a significantly lower nitrogen and raw material environment, navigated a nylon pricing environment pressured by industry supply and demand conditions including increased low-priced imports, while North American acetone supply and demand continued to be balanced. Our team’s collective performance and advantaged business model supporting through-cycle profitability illustrates the value and resilience of our diversified chemistry company. Our confidence is reflected in once again increasing our quarterly cash dividend by 10 percent.”

Summary second quarter 2023 financial results for the Company are included below:


($ in Thousands, Except Earnings Per Share)	2Q 2023	2Q 2022
Sales	$427,940	$583,736
Net Income	32,728	65,157
Diluted Earnings Per Share	$1.16	$2.23
Adjusted Diluted Earnings Per Share (1)	$1.25	$2.30
Adjusted EBITDA (1)	65,785	105,426
Adjusted EBITDA Margin % (1)	15.4%	18.1%
Cash Flow from Operations	35,004	95,891
Free Cash Flow (1)(2)	15,713	78,131

(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations

(2) Net cash provided by operating activities less capital expenditures

Sales of $428 million in the quarter decreased approximately 27% versus the prior year. Market-based pricing was unfavorable by 19% compared to the prior year primarily reflecting lower nutrient values reducing ammonium sulfate pricing, as well as lower nylon pricing. Raw material pass-through pricing was unfavorable by 6% following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products). Sales volume decreased approximately 2% driven by soft end market demand impacting portions of our nylon and chemical intermediates product lines, partially offset by higher domestic ammonium sulfate volume to meet strong in-season customer demand.

Sales by product line and approximate percentage of total sales are included below:


($ in Thousands)	2Q 2023			2Q 2022
	Sales		% of Total	Sales		% of Total
Nylon	$	92,953	22%	$	132,105	23%
Caprolactam	74,682		18%	87,169		15%
Chemical Intermediates	121,365		28%	158,611		27%
Ammonium Sulfate	138,940		32%	205,851		35%
	$	427,940	100%	$	583,736	100%

Adjusted EBITDA of $65.8 million in the quarter decreased $39.6 million versus the prior year primarily due to unfavorable market-based pricing, net of raw material costs, partially offset by the favorable year-over-year impact of planned plant turnarounds, and the net impact of lower sales volume and changes in sales mix including higher domestic plant nutrients sales.

Adjusted earnings per share of $1.25 decreased $1.05 versus the prior year driven primarily by the factors discussed above.

Cash flow from operations of $35.0 million in the quarter decreased $60.9 million versus the prior year

primarily due to lower net income and the unfavorable impact of changes in working capital driven largely by the unwinding of ammonium sulfate pre-buy advances. Capital expenditures of $19.3 million in the quarter increased $1.5 million versus the prior year.

Dividend

The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. This represents a 10% increase from the previous quarter's dividend. The dividend is payable on August 29, 2023 to stockholders of record as of the close of business on August 15, 2023.

Outlook

•Expect favorable underlying agriculture industry fundamentals to continue; Typical North American ammonium sulfate seasonality expected to drive 3Q23 sequential domestic pricing decline

•Expect balanced supply and demand conditions for North American acetone to continue

•Expect continued unfavorable supply and demand conditions across nylon and other chemical intermediates due to headwinds in consumer durables and building and construction end markets

•Continue to expect Capital Expenditures of $110 million to $120 million in 2023, reflecting increased spend due to critical infrastructure, other maintenance, and growth and cost savings projects

•Continue to expect pre-tax income impact of planned plant turnarounds to be $25 million to $30 million in 3Q23, totaling $28 million to $33 million in full year 2023

"We are highly focused on the execution of our upcoming third quarter planned plant turnaround to support safe, stable and sustainable operations at higher utilization rates relative to our industry. While we anticipate the impacts of ammonium sulfate seasonality and soft end market demand overall, we remain well positioned to offer near, medium and long-term value for our shareholders supported by the structural improvements made to the underlying earnings power of this business. We are committed to producing the right chemistries with the right properties to solve our customers' most exciting opportunities, recently illustrated by the introduction of new 100 percent post-consumer recycled content nylon,” concluded Kane.

Conference Call Information

AdvanSix will discuss its results during its investor conference call today starting at 9:00 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. ET start, and tell the operator that you are dialing in for AdvanSix’s second quarter 2023 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on August 4 until 12 noon ET on August 11 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). The access code is 9404240.

About AdvanSix

AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives. Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients. More information on AdvanSix can be found at http://www.advansix.com.

Forward Looking Statements

This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally, including the impact of the coronavirus (COVID-19) pandemic and any resurgences; the potential effects of inflationary pressures, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of the conflict between Russia and Ukraine; the effect on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics and geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022, as updated in subsequent reports filed with the SEC.

Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

# # #


Contacts:
Media			Investors
Janeen Lawlor			Adam Kressel
(973) 526-1615			(973) 526-1700
janeen.lawlor@advansix.com			adam.kressel@advansix.com

AdvanSix Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Dollars in thousands, except share and per share amounts)


	June 30, 2023		December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	10,536	$	30,985
Accounts and other receivables – net	153,148		175,429
Inventories – net	225,986		215,502
Taxes receivable	1,442		9,771
Other current assets	20,043		9,241
Total current assets	411,155		440,928

Property, plant and equipment – net	816,885		811,065
Operating lease right-of-use assets	109,816		114,688
Goodwill	56,192		56,192
Intangible assets	47,717		49,242
Other assets	25,244		23,216
Total assets	$	1,467,009	$	1,495,331

LIABILITIES
Current liabilities:
Accounts payable	$	220,158	$	272,770
Accrued liabilities	43,310		48,820

Operating lease liabilities – short-term	34,342		37,472
Deferred income and customer advances	2,333		34,430
Total current liabilities	300,143		393,492

Deferred income taxes	164,256		160,409
Operating lease liabilities – long-term	75,829		77,571
Line of credit – long-term	140,000		115,000
Postretirement benefit obligations	2,279		—
Other liabilities	10,143		10,679
Total liabilities	692,650		757,151

STOCKHOLDERS' EQUITY
Common stock, par value $0.01; 200,000,000 shares authorized; 32,577,862 shares issued and 27,302,873 outstanding at June 30, 2023; 31,977,593 shares issued and 27,446,520 outstanding at December 31, 2022	326		320
Preferred stock, par value $0.01; 50,000,000 shares authorized and 0 shares issued and outstanding at June 30, 2023 and December 31, 2022	—		—
Treasury stock at par (5,274,989 shares at June 30, 2023; 4,531,073 shares at December 31, 2022)	(53)		(45)
Additional paid-in capital	151,706		174,585
Retained earnings	626,885		567,517
Accumulated other comprehensive loss	(4,505)		(4,197)
Total stockholders' equity	774,359		738,180
Total liabilities and stockholders' equity	$	1,467,009	$	1,495,331

AdvanSix Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Dollars in thousands, except share and per share amounts)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Sales	$	427,940	$	583,736	$	828,484	$	1,062,809

Costs, expenses and other:
Costs of goods sold	360,017		476,835		690,059		852,482
Selling, general and administrative expenses	24,011		20,841		49,126		42,051
Interest expense, net	1,954		769		3,221		1,332
Other non-operating (income) expense, net	(1,325)		172		(1,433)		(431)
Total costs, expenses and other	384,657		498,617		740,973		895,434

Income before taxes	43,283		85,119		87,511		167,375
Income tax expense	10,555		19,962		19,829		39,145
Net income	$	32,728	$	65,157	$	67,682	$	128,230

Earnings per common share
Basic	$	1.19	$	2.31	$	2.46	$	4.55
Diluted	$	1.16	$	2.23	$	2.39	$	4.37

Weighted average common shares outstanding
Basic	27,494,555		28,168,207		27,547,874		28,183,951
Diluted	28,113,402		29,262,709		28,348,266		29,316,792

AdvanSix Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Dollars in thousands)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cash flows from operating activities:
Net income	$	32,728	$	65,157	$	67,682	$	128,230
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	18,113		17,534		35,958		34,226
Loss on disposal of assets	400		441		568		800
Deferred income taxes	4,064		3,077		3,894		2,558
Stock-based compensation	2,436		2,005		4,449		5,379
Amortization of deferred financing fees	154		154		309		309

Changes in assets and liabilities, net of business acquisitions:
Accounts and other receivables	8,116		(23,743)		22,123		(52,145)
Inventories	(1,351)		4,901		(10,484)		3,012
Taxes receivable	(419)		—		8,329		—
Accounts payable	6,172		42,535		(47,216)		52,439

Accrued liabilities	2,664		2,897		(5,744)		(8,821)
Deferred income and customer advances	(23,339)		(827)		(32,097)		(1,142)
Other assets and liabilities	(14,734)		(18,240)		(11,192)		(19,792)
Net cash provided by operating activities	35,004		95,891		36,579		145,053

Cash flows from investing activities:
Expenditures for property, plant and equipment	(19,291)		(17,760)		(43,894)		(38,779)
Acquisition of businesses	—		1,133		—		(97,456)
Other investing activities	(1,031)		(925)		(2,034)		(1,221)
Net cash used for investing activities	(20,322)		(17,552)		(45,928)		(137,456)

Cash flows from financing activities:
Borrowings from line of credit	152,500		82,000		230,500		230,500
Payments of line of credit	(139,500)		(155,500)		(205,500)		(219,000)

Principal payments of finance leases	(225)		(244)		(456)		(481)
Dividend payments	(3,984)		(3,515)		(8,004)		(7,032)
Purchase of treasury stock	(14,886)		(3,407)		(28,385)		(10,419)
Issuance of common stock	123		318		745		1,032
Net cash used for financing activities	(5,972)		(80,348)		(11,100)		(5,400)

Net change in cash and cash equivalents	8,710		(2,009)		(20,449)		2,197
Cash and cash equivalents at beginning of period	1,826		19,306		30,985		15,100
Cash and cash equivalents at the end of period	$	10,536	$	17,297	$	10,536	$	17,297

Supplemental non-cash investing activities:
Capital expenditures included in accounts payable					$	9,832	$	9,207

AdvanSix Inc.

Non-GAAP Measures

(Dollars in thousands, except share and per share amounts)

Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net cash provided by operating activities	$	35,004	$	95,891	$	36,579	$	145,053
Expenditures for property, plant and equipment	(19,291)		(17,760)		(43,894)		(38,779)
Free cash flow (1)	$	15,713	$	78,131	$	(7,315)	$	106,274

(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment

The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net income	$	32,728	$	65,157	$	67,682	$	128,230
Non-cash stock-based compensation	2,436		2,005		4,449		5,379
Non-recurring, unusual or extraordinary expenses	—		—		—		—
Non-cash amortization from acquisitions	532		551		1,064		752
Non-recurring M&A costs	—		—		—		277
Benefit from income taxes relating to reconciling items	(498)		(439)		(933)		(995)
Adjusted Net Income	35,198		67,274		72,262		133,643
Interest expense, net	1,954		769		3,221		1,332
Income tax expense - adjusted	11,053		20,401		20,763		40,141
Depreciation and amortization - adjusted	17,580		16,982		34,893		33,474
Adjusted EBITDA	$	65,785	$	105,426	$	131,139	$	208,590

Sales	$	427,940	$	583,736	$	828,484	$	1,062,809

Adjusted EBITDA Margin (2)	15.4%		18.1%		15.8%		19.6%

(2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net Income	$	32,728	$	65,157	$	67,682	$	128,230
Adjusted Net Income	35,198		67,274		72,262		133,643

Weighted-average number of common shares outstanding - basic	27,494,555		28,168,207		27,547,874		28,183,951
Dilutive effect of equity awards and other stock-based holdings	618,847		1,094,502		800,392		1,132,841
Weighted-average number of common shares outstanding - diluted	28,113,402		29,262,709		28,348,266		29,316,792

EPS - Basic	$	1.19	$	2.31	$	2.46	$	4.55
EPS - Diluted	$	1.16	$	2.23	$	2.39	$	4.37
Adjusted EPS - Basic	$	1.28	$	2.39	$	2.62	$	4.74
Adjusted EPS - Diluted	$	1.25	$	2.30	$	2.55	$	4.56

The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.

AdvanSix Inc.

Appendix

(Pre-tax income impact, Dollars in millions)

Planned Plant Turnaround Schedule (3)

2017

—

~$10

~$4

~$20

~$34

2018

~$2

~$10

~$30

—

~$42

2019

—

~$5

~$25

~$35

2020

~$2

~$7

~$20

~$2

~$31

2021

~$3

~$8

—

~$18

~$29

2022

~$1

~$5

~$44

—

~$50

2023E

~$2

~$1

$25-$30

—

$28-$33

(3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

Cover Page	Aug. 04, 2023
Cover [Abstract]
Document Type	8-K
Document Period End Date	Aug. 04, 2023
Entity Registrant Name	ADVANSIX INC.
Entity Incorporation, State or Country Code	DE
Entity File Number	1-37774
Entity Tax Identification Number	81-2525089
Entity Address, Address Line One	300 Kimball Drive
Entity Address, Address Line Two	Suite 101
Entity Address, City or Town	Parsippany
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07054
City Area Code	973
Local Phone Number	526-1800
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	ASIX
Security Exchange Name	NYSE
Amendment Flag	false
Entity Central Index Key	0001673985